Q/C Technologies, Inc. Amortization of Regulatory Asset
Q/C Technologies, Inc. (QCLS) reported Amortization of Regulatory Asset of $8.73 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfRegulatoryAsset · last filed 2020-08-14
- Q/C Technologies, Inc. amortization of regulatory asset for the quarter ending 2020-06-30 was $8.73K, a 12.75% decline year-over-year.
- Q/C Technologies, Inc. amortization of regulatory asset for the quarter ending 2020-03-31 was $8.87K, a 11.29% decline year-over-year.
- Q/C Technologies, Inc. amortization of regulatory asset for the quarter ending 2019-12-31 was $10.00K, a 76.62% decline year-over-year.
- Q/C Technologies, Inc. amortization of regulatory asset for the quarter ending 2019-09-30 was $10.00K, a 76.62% decline year-over-year.
- Q/C Technologies, Inc. amortization of regulatory asset for fiscal 2019 was $40.01K, a 76.62% decline from fiscal 2018.
- Q/C Technologies, Inc. amortization of regulatory asset for fiscal 2018 was $171.11K, a 0.00% change from fiscal 2017.
- Q/C Technologies, Inc. amortization of regulatory asset for fiscal 2017 was $171.11K, a 0.00% change from fiscal 2016.
- Q/C Technologies, Inc. amortization of regulatory asset for fiscal 2016 was $171.11K, a 27.71% decline from fiscal 2015.
| Period end | Amortization of Regulatory Asset 3 month | Amortization of Regulatory Asset 6 month | Amortization of Regulatory Asset 9 month | Amortization of Regulatory Asset 12 month |
|---|---|---|---|---|
| 2020-06-30 | $8.73K 10-Q · filed 2020-08-14 | $17.60K 10-Q · filed 2020-08-14 | $27.60K derived: sum of 3 quarters · filed 2020-08-14 | $37.60K derived: sum of 4 quarters · filed 2020-08-14 |
| 2020-03-31 | $8.87K 10-Q · filed 2020-05-15 | $18.88K derived: sum of 2 quarters · filed 2020-05-15 | $28.88K derived: sum of 3 quarters · filed 2020-05-15 | $38.88K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $20.00K derived: sum of 2 quarters · filed 2020-03-25 | $30.00K derived: sum of 3 quarters · filed 2020-08-14 | $40.01K 10-K · filed 2020-03-25 |
| 2019-09-30 | $10.00K 10-Q · filed 2019-11-14 | $20.00K derived: sum of 2 quarters · filed 2020-08-14 | $30.01K 10-Q · filed 2019-11-14 | $72.78K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-06-30 | $10.00K 10-Q · filed 2020-08-14 | $20.00K 10-Q · filed 2020-08-14 | $62.78K derived: sum of 3 quarters · filed 2020-08-14 | $105.56K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $10.00K 10-Q · filed 2020-05-15 | $52.78K derived: sum of 2 quarters · filed 2020-05-15 | $95.56K derived: sum of 3 quarters · filed 2020-05-15 | $138.33K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $42.78K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $85.55K derived: sum of 2 quarters · filed 2020-03-25 | $128.33K derived: sum of 3 quarters · filed 2020-03-25 | $171.11K 10-K · filed 2020-03-25 |
| 2018-09-30 | $42.78K 10-Q · filed 2019-11-14 | $85.55K derived: sum of 2 quarters · filed 2019-11-14 | $128.33K 10-Q · filed 2019-11-14 | $171.11K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $42.78K 10-Q · filed 2019-08-14 | $85.55K 10-Q · filed 2019-08-14 | $128.33K derived: sum of 3 quarters · filed 2019-08-14 | $171.11K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $42.78K 10-Q · filed 2019-05-20 | $85.55K derived: sum of 2 quarters · filed 2019-05-20 | $128.33K derived: sum of 3 quarters · filed 2019-05-20 | $171.11K derived: sum of 4 quarters · filed 2019-05-20 |
| 2017-12-31 | $42.78K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $85.55K derived: sum of 2 quarters · filed 2019-04-01 | $128.33K derived: sum of 3 quarters · filed 2019-04-01 | $171.11K 10-K · filed 2019-04-01 |
| 2017-09-30 | $42.78K 10-Q · filed 2018-11-14 | $85.55K derived: sum of 2 quarters · filed 2018-11-14 | $128.33K 10-Q · filed 2018-11-14 | $171.11K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $42.78K 10-Q · filed 2018-08-14 | $85.55K 10-Q · filed 2018-08-14 | $128.33K derived: sum of 3 quarters · filed 2018-08-14 | $171.11K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $42.78K 10-Q · filed 2018-07-13 | $85.55K derived: sum of 2 quarters · filed 2018-07-13 | $128.33K derived: sum of 3 quarters · filed 2018-07-13 | $171.11K derived: sum of 4 quarters · filed 2018-07-13 |
| 2016-12-31 | $42.78K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-07-13 | $85.55K derived: sum of 2 quarters · filed 2018-07-13 | $128.33K derived: sum of 3 quarters · filed 2018-07-13 | $171.11K 10-K/A · filed 2018-07-13 |
| 2016-09-30 | $42.78K 10-Q/A · filed 2018-07-13 | $85.55K derived: sum of 2 quarters · filed 2018-07-13 | $128.33K 10-Q/A · filed 2018-07-13 | $171.11K derived: sum of 4 quarters · filed 2018-07-13 |
| 2016-06-30 | $42.78K 10-Q/A · filed 2018-07-13 | $85.55K 10-Q/A · filed 2018-07-13 | $128.33K derived: sum of 3 quarters · filed 2018-07-13 | $192.97K derived: sum of 4 quarters · filed 2018-07-13 |
| 2016-03-31 | $42.78K 10-Q · filed 2017-05-15 | $85.55K derived: sum of 2 quarters · filed 2017-05-15 | $150.20K derived: sum of 3 quarters · filed 2017-05-15 | $214.84K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $42.78K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11 | $107.42K derived: sum of 2 quarters · filed 2017-04-11 | $172.06K derived: sum of 3 quarters · filed 2017-04-11 | $236.71K 10-K · filed 2017-04-11 |
| 2015-09-30 | $64.64K 10-Q · filed 2016-11-14 | $129.29K derived: sum of 2 quarters · filed 2016-11-14 | $193.93K 10-Q · filed 2016-11-14 | $258.57K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $64.64K 10-Q · filed 2016-08-11 | $129.29K 10-Q · filed 2016-08-11 | $193.93K derived: sum of 3 quarters · filed 2016-08-11 | $258.57K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $64.64K 10-Q · filed 2016-05-12 | $129.29K derived: sum of 2 quarters · filed 2016-05-12 | $193.93K derived: sum of 3 quarters · filed 2016-05-12 | $258.57K derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | $64.64K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $129.29K derived: sum of 2 quarters · filed 2016-03-30 | $193.93K derived: sum of 3 quarters · filed 2016-03-30 | $258.57K 10-K · filed 2016-03-30 |
| 2014-09-30 | $64.64K 10-Q · filed 2015-11-13 | $129.29K derived: sum of 2 quarters · filed 2015-11-13 | $193.93K 10-Q · filed 2015-11-13 | $258.57K derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | $64.64K 10-Q · filed 2015-08-18 | $129.29K 10-Q · filed 2015-08-18 | $193.93K derived: sum of 3 quarters · filed 2015-08-18 | $258.57K derived: sum of 4 quarters · filed 2015-08-18 |
| 2014-03-31 | $64.64K 10-Q · filed 2015-05-14 | $129.29K derived: sum of 2 quarters · filed 2015-05-14 | $193.93K derived: sum of 3 quarters · filed 2015-05-14 | $258.57K derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | $64.64K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $129.29K derived: sum of 2 quarters · filed 2015-03-23 | $193.93K derived: sum of 3 quarters · filed 2015-03-23 | $258.57K 10-K · filed 2015-03-23 |
| 2013-09-30 | $64.64K 10-Q · filed 2014-11-13 | $129.29K derived: sum of 2 quarters · filed 2014-11-13 | $193.93K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $64.64K 10-Q · filed 2014-08-12 | $129.29K 10-Q · filed 2014-08-12 | ||
| 2013-03-31 | $64.64K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |